Global Non-Invasive Prenatal Screening (NIPS) Supply, Demand and Key Producers, 2026-2032
The global Non-Invasive Prenatal Screening (NIPS) market size is expected to reach $ 6028 million by 2032, rising at a market growth of 6.9% CAGR during the forecast period (2026-2032).
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
This report studies the global Non-Invasive Prenatal Screening (NIPS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Invasive Prenatal Screening (NIPS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Invasive Prenatal Screening (NIPS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Invasive Prenatal Screening (NIPS) total market, 2021-2032, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-Invasive Prenatal Screening (NIPS) total market, key domestic companies, and share, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-Invasive Prenatal Screening (NIPS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Veritas Genetics, GGA, Cordlife, BGI Genomics, Berry Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-Invasive Prenatal Screening (NIPS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-Invasive Prenatal Screening (NIPS) Market, By Region:
1. How big is the global Non-Invasive Prenatal Screening (NIPS) market?
2. What is the demand of the global Non-Invasive Prenatal Screening (NIPS) market?
3. What is the year over year growth of the global Non-Invasive Prenatal Screening (NIPS) market?
4. What is the total value of the global Non-Invasive Prenatal Screening (NIPS) market?
5. Who are the Major Players in the global Non-Invasive Prenatal Screening (NIPS) market?
6. What are the growth factors driving the market demand?
Non-Invasive Prenatal Screening (NIPS) is a prenatal testing method that analyzes genetic material from a pregnancy related blood sample to assess the risk of certain chromosomal or genetic conditions in the fetus without posing physical risk to the pregnancy. It is designed as a screening tool rather than a diagnostic test and is used to identify pregnancies that may benefit from further confirmatory testing and specialized clinical management.
The non invasive prenatal screening market has transitioned from a niche offering for high risk pregnancies into a mainstream component of prenatal care, driven by its strong clinical performance, low procedural risk, and growing acceptance among clinicians and expectant parents. Market dynamics are shaped by rapid technological standardization, intensifying competition, and gradual price compression, which together shift differentiation away from basic test availability toward service quality, turnaround time, reporting clarity, and integration with counseling and follow up pathways. While growth remains robust due to expanding geographic adoption and broader clinical indications, the market is increasingly influenced by reimbursement policy, ethical oversight, and evidence based guideline updates, positioning it as a mature but still structurally expanding segment within prenatal diagnostics.
This report studies the global Non-Invasive Prenatal Screening (NIPS) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Invasive Prenatal Screening (NIPS), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Invasive Prenatal Screening (NIPS) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Invasive Prenatal Screening (NIPS) total market, 2021-2032, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Non-Invasive Prenatal Screening (NIPS) total market, key domestic companies, and share, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by Type, CAGR, 2021-2032, (USD Million)
Global Non-Invasive Prenatal Screening (NIPS) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Non-Invasive Prenatal Screening (NIPS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, SYNLAB, Veritas Genetics, GGA, Cordlife, BGI Genomics, Berry Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Non-Invasive Prenatal Screening (NIPS) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-Invasive Prenatal Screening (NIPS) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Screening in Uncomplicated Pregnancies
- Screening in High-Risk Pregnancies
- Others
- First-trimester Screening
- Second-trimester Screening
- Late-pregnancy Screening
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
1. How big is the global Non-Invasive Prenatal Screening (NIPS) market?
2. What is the demand of the global Non-Invasive Prenatal Screening (NIPS) market?
3. What is the year over year growth of the global Non-Invasive Prenatal Screening (NIPS) market?
4. What is the total value of the global Non-Invasive Prenatal Screening (NIPS) market?
5. Who are the Major Players in the global Non-Invasive Prenatal Screening (NIPS) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-Invasive Prenatal Screening (NIPS) Introduction
1.2 World Non-Invasive Prenatal Screening (NIPS) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-Invasive Prenatal Screening (NIPS) Total Market by Region (by Headquarter Location)
1.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.3 China Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.4 Europe Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.5 Japan Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.6 South Korea Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.8 India Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Invasive Prenatal Screening (NIPS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.2 World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region
2.2.1 World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026)
2.2.2 World Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.4 China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.5 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.6 Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.7 South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.8 ASEAN Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.9 India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
3 WORLD NON-INVASIVE PRENATAL SCREENING (NIPS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Invasive Prenatal Screening (NIPS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Invasive Prenatal Screening (NIPS) in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-Invasive Prenatal Screening (NIPS) in 2025
3.3 Non-Invasive Prenatal Screening (NIPS) Company Evaluation Quadrant
3.4 Non-Invasive Prenatal Screening (NIPS) Market: Overall Company Footprint Analysis
3.4.1 Non-Invasive Prenatal Screening (NIPS) Market: Region Footprint
3.4.2 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
3.4.3 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison
4.2.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-Invasive Prenatal Screening (NIPS) Companies and Market Share, 2021-2026
4.3.1 United States Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026)
4.4 China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue and Market Share, 2021-2026
4.4.1 China Based Non-Invasive Prenatal Screening (NIPS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026)
4.5 Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Screening in Uncomplicated Pregnancies
5.2.2 Screening in High-Risk Pregnancies
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
5.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
5.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TIMING
6.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Screening Timing: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Timing
6.2.1 First-trimester Screening
6.2.2 Second-trimester Screening
6.2.3 Late-pregnancy Screening
6.3 Market Segment by Screening Timing
6.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2021-2026)
6.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2027-2032)
6.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2021-2026)
7.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2027-2032)
7.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
8.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
8.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Revvity
9.1.1 Revvity Details
9.1.2 Revvity Major Business
9.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Product and Services
9.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Revvity Recent Developments/Updates
9.1.6 Revvity Competitive Strengths & Weaknesses
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Details
9.2.2 Quest Diagnostics Major Business
9.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Quest Diagnostics Recent Developments/Updates
9.2.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.3 MedGenome
9.3.1 MedGenome Details
9.3.2 MedGenome Major Business
9.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Services
9.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 MedGenome Recent Developments/Updates
9.3.6 MedGenome Competitive Strengths & Weaknesses
9.4 Mayo Clinic Laboratories
9.4.1 Mayo Clinic Laboratories Details
9.4.2 Mayo Clinic Laboratories Major Business
9.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Services
9.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Mayo Clinic Laboratories Recent Developments/Updates
9.4.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.5 SYNLAB
9.5.1 SYNLAB Details
9.5.2 SYNLAB Major Business
9.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Services
9.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 SYNLAB Recent Developments/Updates
9.5.6 SYNLAB Competitive Strengths & Weaknesses
9.6 Veritas Genetics
9.6.1 Veritas Genetics Details
9.6.2 Veritas Genetics Major Business
9.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Veritas Genetics Recent Developments/Updates
9.6.6 Veritas Genetics Competitive Strengths & Weaknesses
9.7 GGA
9.7.1 GGA Details
9.7.2 GGA Major Business
9.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Product and Services
9.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 GGA Recent Developments/Updates
9.7.6 GGA Competitive Strengths & Weaknesses
9.8 Cordlife
9.8.1 Cordlife Details
9.8.2 Cordlife Major Business
9.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Services
9.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Cordlife Recent Developments/Updates
9.8.6 Cordlife Competitive Strengths & Weaknesses
9.9 BGI Genomics
9.9.1 BGI Genomics Details
9.9.2 BGI Genomics Major Business
9.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Genomics Recent Developments/Updates
9.9.6 BGI Genomics Competitive Strengths & Weaknesses
9.10 Berry Genomics
9.10.1 Berry Genomics Details
9.10.2 Berry Genomics Major Business
9.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Genomics Recent Developments/Updates
9.10.6 Berry Genomics Competitive Strengths & Weaknesses
9.11 Annaroad
9.11.1 Annaroad Details
9.11.2 Annaroad Major Business
9.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Services
9.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Annaroad Recent Developments/Updates
9.11.6 Annaroad Competitive Strengths & Weaknesses
9.12 Genesky
9.12.1 Genesky Details
9.12.2 Genesky Major Business
9.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Product and Services
9.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Genesky Recent Developments/Updates
9.12.6 Genesky Competitive Strengths & Weaknesses
9.13 Weihansi Biomedical Technology
9.13.1 Weihansi Biomedical Technology Details
9.13.2 Weihansi Biomedical Technology Major Business
9.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Services
9.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Weihansi Biomedical Technology Recent Developments/Updates
9.13.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-Invasive Prenatal Screening (NIPS) Industry Chain
10.2 Non-Invasive Prenatal Screening (NIPS) Upstream Analysis
10.3 Non-Invasive Prenatal Screening (NIPS) Midstream Analysis
10.4 Non-Invasive Prenatal Screening (NIPS) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Non-Invasive Prenatal Screening (NIPS) Introduction
1.2 World Non-Invasive Prenatal Screening (NIPS) Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Non-Invasive Prenatal Screening (NIPS) Total Market by Region (by Headquarter Location)
1.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.3 China Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.4 Europe Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.5 Japan Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.6 South Korea Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.7 ASEAN Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.3.8 India Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Invasive Prenatal Screening (NIPS) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.2 World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region
2.2.1 World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026)
2.2.2 World Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Region (2027-2032)
2.3 United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.4 China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.5 Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.6 Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.7 South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.8 ASEAN Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
2.9 India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032)
3 WORLD NON-INVASIVE PRENATAL SCREENING (NIPS) COMPANIES COMPETITIVE ANALYSIS
3.1 World Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Non-Invasive Prenatal Screening (NIPS) Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Non-Invasive Prenatal Screening (NIPS) in 2025
3.2.3 Global Concentration Ratios (CR8) for Non-Invasive Prenatal Screening (NIPS) in 2025
3.3 Non-Invasive Prenatal Screening (NIPS) Company Evaluation Quadrant
3.4 Non-Invasive Prenatal Screening (NIPS) Market: Overall Company Footprint Analysis
3.4.1 Non-Invasive Prenatal Screening (NIPS) Market: Region Footprint
3.4.2 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
3.4.3 Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison
4.2.1 United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Non-Invasive Prenatal Screening (NIPS) Companies and Market Share, 2021-2026
4.3.1 United States Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026)
4.4 China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue and Market Share, 2021-2026
4.4.1 China Based Non-Invasive Prenatal Screening (NIPS) Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026)
4.5 Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Screening in Uncomplicated Pregnancies
5.2.2 Screening in High-Risk Pregnancies
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2021-2026)
5.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032)
5.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SCREENING TIMING
6.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Screening Timing: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Screening Timing
6.2.1 First-trimester Screening
6.2.2 Second-trimester Screening
6.2.3 Late-pregnancy Screening
6.3 Market Segment by Screening Timing
6.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2021-2026)
6.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2027-2032)
6.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2027-2032)
7 MARKET ANALYSIS BY SERVICE MODEL
7.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Service Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Model
7.2.1 Public Health Program
7.2.2 Consumer
7.2.3 Others
7.3 Market Segment by Service Model
7.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2021-2026)
7.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2027-2032)
7.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Non-Invasive Prenatal Screening (NIPS) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Public Hospitals
8.2.2 Private Hospitals
8.3 Market Segment by Application
8.3.1 World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026)
8.3.2 World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032)
8.3.3 World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Revvity
9.1.1 Revvity Details
9.1.2 Revvity Major Business
9.1.3 Revvity Non-Invasive Prenatal Screening (NIPS) Product and Services
9.1.4 Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Revvity Recent Developments/Updates
9.1.6 Revvity Competitive Strengths & Weaknesses
9.2 Quest Diagnostics
9.2.1 Quest Diagnostics Details
9.2.2 Quest Diagnostics Major Business
9.2.3 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.2.4 Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Quest Diagnostics Recent Developments/Updates
9.2.6 Quest Diagnostics Competitive Strengths & Weaknesses
9.3 MedGenome
9.3.1 MedGenome Details
9.3.2 MedGenome Major Business
9.3.3 MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Services
9.3.4 MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 MedGenome Recent Developments/Updates
9.3.6 MedGenome Competitive Strengths & Weaknesses
9.4 Mayo Clinic Laboratories
9.4.1 Mayo Clinic Laboratories Details
9.4.2 Mayo Clinic Laboratories Major Business
9.4.3 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Services
9.4.4 Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Mayo Clinic Laboratories Recent Developments/Updates
9.4.6 Mayo Clinic Laboratories Competitive Strengths & Weaknesses
9.5 SYNLAB
9.5.1 SYNLAB Details
9.5.2 SYNLAB Major Business
9.5.3 SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Services
9.5.4 SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 SYNLAB Recent Developments/Updates
9.5.6 SYNLAB Competitive Strengths & Weaknesses
9.6 Veritas Genetics
9.6.1 Veritas Genetics Details
9.6.2 Veritas Genetics Major Business
9.6.3 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.6.4 Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Veritas Genetics Recent Developments/Updates
9.6.6 Veritas Genetics Competitive Strengths & Weaknesses
9.7 GGA
9.7.1 GGA Details
9.7.2 GGA Major Business
9.7.3 GGA Non-Invasive Prenatal Screening (NIPS) Product and Services
9.7.4 GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 GGA Recent Developments/Updates
9.7.6 GGA Competitive Strengths & Weaknesses
9.8 Cordlife
9.8.1 Cordlife Details
9.8.2 Cordlife Major Business
9.8.3 Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Services
9.8.4 Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Cordlife Recent Developments/Updates
9.8.6 Cordlife Competitive Strengths & Weaknesses
9.9 BGI Genomics
9.9.1 BGI Genomics Details
9.9.2 BGI Genomics Major Business
9.9.3 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.9.4 BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 BGI Genomics Recent Developments/Updates
9.9.6 BGI Genomics Competitive Strengths & Weaknesses
9.10 Berry Genomics
9.10.1 Berry Genomics Details
9.10.2 Berry Genomics Major Business
9.10.3 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
9.10.4 Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Berry Genomics Recent Developments/Updates
9.10.6 Berry Genomics Competitive Strengths & Weaknesses
9.11 Annaroad
9.11.1 Annaroad Details
9.11.2 Annaroad Major Business
9.11.3 Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Services
9.11.4 Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Annaroad Recent Developments/Updates
9.11.6 Annaroad Competitive Strengths & Weaknesses
9.12 Genesky
9.12.1 Genesky Details
9.12.2 Genesky Major Business
9.12.3 Genesky Non-Invasive Prenatal Screening (NIPS) Product and Services
9.12.4 Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Genesky Recent Developments/Updates
9.12.6 Genesky Competitive Strengths & Weaknesses
9.13 Weihansi Biomedical Technology
9.13.1 Weihansi Biomedical Technology Details
9.13.2 Weihansi Biomedical Technology Major Business
9.13.3 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Services
9.13.4 Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Weihansi Biomedical Technology Recent Developments/Updates
9.13.6 Weihansi Biomedical Technology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Non-Invasive Prenatal Screening (NIPS) Industry Chain
10.2 Non-Invasive Prenatal Screening (NIPS) Upstream Analysis
10.3 Non-Invasive Prenatal Screening (NIPS) Midstream Analysis
10.4 Non-Invasive Prenatal Screening (NIPS) Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-Invasive Prenatal Screening (NIPS) Players in 2025
Table 12. World Non-Invasive Prenatal Screening (NIPS) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-Invasive Prenatal Screening (NIPS) Company Evaluation Quadrant
Table 14. Head Office of Key Non-Invasive Prenatal Screening (NIPS) Players
Table 15. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
Table 16. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
Table 17. Non-Invasive Prenatal Screening (NIPS) Mergers & Acquisitions Activity
Table 18. United States VS China Non-Invasive Prenatal Screening (NIPS) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 23. China Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 29. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Screening Timing (2021-2026) & (USD Million)
Table 34. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2027-2032) & (USD Million)
Table 35. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (USD Million)
Table 41. Revvity Basic Information, Manufacturing Base and Competitors
Table 42. Revvity Major Business
Table 43. Revvity Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 44. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Revvity Recent Developments/Updates
Table 46. Revvity Competitive Strengths & Weaknesses
Table 47. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Quest Diagnostics Major Business
Table 49. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 50. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Quest Diagnostics Recent Developments/Updates
Table 52. Quest Diagnostics Competitive Strengths & Weaknesses
Table 53. MedGenome Basic Information, Manufacturing Base and Competitors
Table 54. MedGenome Major Business
Table 55. MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 56. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. MedGenome Recent Developments/Updates
Table 58. MedGenome Competitive Strengths & Weaknesses
Table 59. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Mayo Clinic Laboratories Major Business
Table 61. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 62. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Mayo Clinic Laboratories Recent Developments/Updates
Table 64. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 65. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 66. SYNLAB Major Business
Table 67. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 68. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. SYNLAB Recent Developments/Updates
Table 70. SYNLAB Competitive Strengths & Weaknesses
Table 71. Veritas Genetics Basic Information, Manufacturing Base and Competitors
Table 72. Veritas Genetics Major Business
Table 73. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 74. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Veritas Genetics Recent Developments/Updates
Table 76. Veritas Genetics Competitive Strengths & Weaknesses
Table 77. GGA Basic Information, Manufacturing Base and Competitors
Table 78. GGA Major Business
Table 79. GGA Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 80. GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. GGA Recent Developments/Updates
Table 82. GGA Competitive Strengths & Weaknesses
Table 83. Cordlife Basic Information, Manufacturing Base and Competitors
Table 84. Cordlife Major Business
Table 85. Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 86. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cordlife Recent Developments/Updates
Table 88. Cordlife Competitive Strengths & Weaknesses
Table 89. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 90. BGI Genomics Major Business
Table 91. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 92. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Genomics Recent Developments/Updates
Table 94. BGI Genomics Competitive Strengths & Weaknesses
Table 95. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Berry Genomics Major Business
Table 97. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 98. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Genomics Recent Developments/Updates
Table 100. Berry Genomics Competitive Strengths & Weaknesses
Table 101. Annaroad Basic Information, Manufacturing Base and Competitors
Table 102. Annaroad Major Business
Table 103. Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 104. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Annaroad Recent Developments/Updates
Table 106. Annaroad Competitive Strengths & Weaknesses
Table 107. Genesky Basic Information, Manufacturing Base and Competitors
Table 108. Genesky Major Business
Table 109. Genesky Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 110. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Genesky Recent Developments/Updates
Table 112. Genesky Competitive Strengths & Weaknesses
Table 113. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 114. Weihansi Biomedical Technology Major Business
Table 115. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 116. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Weihansi Biomedical Technology Recent Developments/Updates
Table 118. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 119. Global Key Players of Non-Invasive Prenatal Screening (NIPS) Upstream (Raw Materials)
Table 120. Global Non-Invasive Prenatal Screening (NIPS) Typical Customers
Table 1. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Non-Invasive Prenatal Screening (NIPS) Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Non-Invasive Prenatal Screening (NIPS) Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Non-Invasive Prenatal Screening (NIPS) Players in 2025
Table 12. World Non-Invasive Prenatal Screening (NIPS) Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Non-Invasive Prenatal Screening (NIPS) Company Evaluation Quadrant
Table 14. Head Office of Key Non-Invasive Prenatal Screening (NIPS) Players
Table 15. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Type Footprint
Table 16. Non-Invasive Prenatal Screening (NIPS) Market: Company Product Application Footprint
Table 17. Non-Invasive Prenatal Screening (NIPS) Mergers & Acquisitions Activity
Table 18. United States VS China Non-Invasive Prenatal Screening (NIPS) Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Non-Invasive Prenatal Screening (NIPS) Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (States, Country)
Table 21. United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 23. China Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
Table 24. China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 26. Rest of World Based Non-Invasive Prenatal Screening (NIPS) Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Non-Invasive Prenatal Screening (NIPS) Revenue Market Share (2021-2026)
Table 29. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2027-2032) & (USD Million)
Table 32. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 33. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Screening Timing (2021-2026) & (USD Million)
Table 34. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing (2027-2032) & (USD Million)
Table 35. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Table 36. World Non-Invasive Prenatal Screening (NIPS) Market Size Value by Service Model (2021-2026) & (USD Million)
Table 37. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model (2027-2032) & (USD Million)
Table 38. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2021-2026) & (USD Million)
Table 40. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2027-2032) & (USD Million)
Table 41. Revvity Basic Information, Manufacturing Base and Competitors
Table 42. Revvity Major Business
Table 43. Revvity Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 44. Revvity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Revvity Recent Developments/Updates
Table 46. Revvity Competitive Strengths & Weaknesses
Table 47. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Quest Diagnostics Major Business
Table 49. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 50. Quest Diagnostics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Quest Diagnostics Recent Developments/Updates
Table 52. Quest Diagnostics Competitive Strengths & Weaknesses
Table 53. MedGenome Basic Information, Manufacturing Base and Competitors
Table 54. MedGenome Major Business
Table 55. MedGenome Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 56. MedGenome Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. MedGenome Recent Developments/Updates
Table 58. MedGenome Competitive Strengths & Weaknesses
Table 59. Mayo Clinic Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Mayo Clinic Laboratories Major Business
Table 61. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 62. Mayo Clinic Laboratories Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Mayo Clinic Laboratories Recent Developments/Updates
Table 64. Mayo Clinic Laboratories Competitive Strengths & Weaknesses
Table 65. SYNLAB Basic Information, Manufacturing Base and Competitors
Table 66. SYNLAB Major Business
Table 67. SYNLAB Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 68. SYNLAB Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. SYNLAB Recent Developments/Updates
Table 70. SYNLAB Competitive Strengths & Weaknesses
Table 71. Veritas Genetics Basic Information, Manufacturing Base and Competitors
Table 72. Veritas Genetics Major Business
Table 73. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 74. Veritas Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Veritas Genetics Recent Developments/Updates
Table 76. Veritas Genetics Competitive Strengths & Weaknesses
Table 77. GGA Basic Information, Manufacturing Base and Competitors
Table 78. GGA Major Business
Table 79. GGA Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 80. GGA Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. GGA Recent Developments/Updates
Table 82. GGA Competitive Strengths & Weaknesses
Table 83. Cordlife Basic Information, Manufacturing Base and Competitors
Table 84. Cordlife Major Business
Table 85. Cordlife Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 86. Cordlife Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Cordlife Recent Developments/Updates
Table 88. Cordlife Competitive Strengths & Weaknesses
Table 89. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 90. BGI Genomics Major Business
Table 91. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 92. BGI Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. BGI Genomics Recent Developments/Updates
Table 94. BGI Genomics Competitive Strengths & Weaknesses
Table 95. Berry Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Berry Genomics Major Business
Table 97. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 98. Berry Genomics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Berry Genomics Recent Developments/Updates
Table 100. Berry Genomics Competitive Strengths & Weaknesses
Table 101. Annaroad Basic Information, Manufacturing Base and Competitors
Table 102. Annaroad Major Business
Table 103. Annaroad Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 104. Annaroad Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Annaroad Recent Developments/Updates
Table 106. Annaroad Competitive Strengths & Weaknesses
Table 107. Genesky Basic Information, Manufacturing Base and Competitors
Table 108. Genesky Major Business
Table 109. Genesky Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 110. Genesky Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Genesky Recent Developments/Updates
Table 112. Genesky Competitive Strengths & Weaknesses
Table 113. Weihansi Biomedical Technology Basic Information, Manufacturing Base and Competitors
Table 114. Weihansi Biomedical Technology Major Business
Table 115. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Product and Services
Table 116. Weihansi Biomedical Technology Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Weihansi Biomedical Technology Recent Developments/Updates
Table 118. Weihansi Biomedical Technology Competitive Strengths & Weaknesses
Table 119. Global Key Players of Non-Invasive Prenatal Screening (NIPS) Upstream (Raw Materials)
Table 120. Global Non-Invasive Prenatal Screening (NIPS) Typical Customers
LIST OF FIGURES
Figure 1. Non-Invasive Prenatal Screening (NIPS) Picture
Figure 2. World Non-Invasive Prenatal Screening (NIPS) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-Invasive Prenatal Screening (NIPS) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 13. Non-Invasive Prenatal Screening (NIPS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-Invasive Prenatal Screening (NIPS) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Invasive Prenatal Screening (NIPS) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Invasive Prenatal Screening (NIPS) Markets in 2025
Figure 27. United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2025
Figure 31. Screening in Uncomplicated Pregnancies
Figure 32. Screening in High-Risk Pregnancies
Figure 33. Others
Figure 34. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2032)
Figure 35. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 36. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing in 2025
Figure 37. First-trimester Screening
Figure 38. Second-trimester Screening
Figure 39. Late-pregnancy Screening
Figure 40. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2032)
Figure 41. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 42. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model in 2025
Figure 43. Public Health Program
Figure 44. Consumer
Figure 45. Others
Figure 46. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2032)
Figure 47. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2025
Figure 49. Public Hospitals
Figure 50. Private Hospitals
Figure 51. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2032)
Figure 52. Non-Invasive Prenatal Screening (NIPS) Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Non-Invasive Prenatal Screening (NIPS) Picture
Figure 2. World Non-Invasive Prenatal Screening (NIPS) Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-Invasive Prenatal Screening (NIPS) Total Revenue (2021-2032) & (USD Million)
Figure 4. World Non-Invasive Prenatal Screening (NIPS) Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Non-Invasive Prenatal Screening (NIPS) Revenue (2021-2032) & (USD Million)
Figure 13. Non-Invasive Prenatal Screening (NIPS) Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 16. World Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 18. China Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 23. India Non-Invasive Prenatal Screening (NIPS) Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Non-Invasive Prenatal Screening (NIPS) by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Non-Invasive Prenatal Screening (NIPS) Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Non-Invasive Prenatal Screening (NIPS) Markets in 2025
Figure 27. United States VS China: Non-Invasive Prenatal Screening (NIPS) Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-Invasive Prenatal Screening (NIPS) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Non-Invasive Prenatal Screening (NIPS) Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2025
Figure 31. Screening in Uncomplicated Pregnancies
Figure 32. Screening in High-Risk Pregnancies
Figure 33. Others
Figure 34. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2021-2032)
Figure 35. World Non-Invasive Prenatal Screening (NIPS) Market Size by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 36. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing in 2025
Figure 37. First-trimester Screening
Figure 38. Second-trimester Screening
Figure 39. Late-pregnancy Screening
Figure 40. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Screening Timing (2021-2032)
Figure 41. World Non-Invasive Prenatal Screening (NIPS) Market Size by Service Model, (USD Million), 2021 & 2025 & 2032
Figure 42. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model in 2025
Figure 43. Public Health Program
Figure 44. Consumer
Figure 45. Others
Figure 46. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Service Model (2021-2032)
Figure 47. World Non-Invasive Prenatal Screening (NIPS) Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2025
Figure 49. Public Hospitals
Figure 50. Private Hospitals
Figure 51. World Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2021-2032)
Figure 52. Non-Invasive Prenatal Screening (NIPS) Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
